Pharmaceutical giant Bayer is facing legal action from thousands of plaintiffs who claim they or their loved ones have been injured by the Yasmin line of oral contraceptives.
The complaints about the Yasmin line of contraceptives cite a number of studies indicating that birth control pills with the compound drospirenone carry up to three times the risk of potentially fatal blood clots as other oral contraceptives on the market.
But according to a story on CBS’s Money Watch, Bayer is facing legal action over its anti-bleeding drug, Trasylol.
The report concerns a woman who filed suit over allegations that her husband died because Trasylol was used in his coronary artery bypass surgery. According to the story Bayer learned of the lawsuit the same day a study of 49 randomized trials of Trasylol showed it carries a higher risk of death than for alternative drugs.
The plaintiff claimed that her husband suffered acute renal failure after undergoing the surgery at St. Vincent’s Hospital in Birgingham, Ala., in October 2006.
In the study, Canadian and Australian researchers concluded that: “While Trasylol was somewhat more effective at controlling blood loss and transfusions than lysine analogues, its higher risk of death and significantly higher price are deterrents to its use.”
Bayer removed Trasylol from the U.S. market in 2007. And although the company claimed that worldwide shipment were also halted that year, it was reportedly still being sold in some parts of the world.
Patients should consult their doctors before making any changes in their medication. A consultation with a Beyaz lawyer or a Trasylol lawyer is also important if there are significant injuries while on Beyaz or similar birth control pills.
See the story here: